Atlas Trials

Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Clinical trial NCT00602147 · TERMINATED

Trial details

NCT number
NCT00602147
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
MucositisMultiple Myeloma and Plasma Cell Neoplasm
Start date
2007-07-01
Primary completion
2009-01-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.